Probing Dry-Weight Improves Left Ventricular Mass Index
暂无分享,去创建一个
[1] G. Beck,et al. In-center hemodialysis six times per week versus three times per week. , 2010, The New England journal of medicine.
[2] R. Agarwal,et al. Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial , 2009, Hypertension.
[3] O. Ozdogan,et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] R. Light,et al. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] N. Bodyak,et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals , 2007, Proceedings of the National Academy of Sciences.
[6] C. Saha,et al. Out-of-Hemodialysis-Unit Blood Pressure Is a Superior Determinant of Left Ventricular Hypertrophy , 2006, Hypertension.
[7] Jeffrey C. Hill,et al. Analysis of left ventricular systolic function using midwall mechanics in patients >60 years of age with hypertensive heart disease and heart failure. , 2005, The American journal of cardiology.
[8] J. Singer,et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] A. Go,et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. , 2005, Journal of the American Society of Nephrology : JASN.
[10] M. Nieminen,et al. Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.
[11] David Voss,et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. , 2004, Journal of the American Society of Nephrology : JASN.
[12] E. Ok,et al. Impact of volume control on left ventricular hypertrophy in dialysis patients. , 2002, Journal of nephrology.
[13] C. Specchia,et al. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] Christopher T. Chan,et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. , 2002, Kidney international.
[15] J. Blacher,et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. , 2001, Journal of the American Society of Nephrology : JASN.
[16] C. Zoccali,et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. , 2001, Journal of the American Society of Nephrology : JASN.
[17] J. Singer,et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] C. Park,et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] F. Akçiçek,et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] D. Rolla,et al. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] J. Singer,et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] G. Aurigemma,et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. , 1995, Journal of the American College of Cardiology.
[23] E. Paoletti,et al. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. , 1993, Kidney international.
[24] W. Kannel. Left ventricular hypertrophy as a risk factor: the Framingham experience , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[25] E. Movilli,et al. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[26] D E Manyari,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[27] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.